RTW Biotech Opportunities Ltd
RTWFF
$1.20
$0.010.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 132.83% | 132.83% | 52.24% | 52.24% | 55.50% |
| Total Revenue | 132.83% | 132.83% | 52.24% | 52.24% | 55.50% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 132.83% | 132.83% | 52.24% | 52.24% | 55.50% |
| SG&A Expenses | 79.48% | 79.48% | 58.32% | 58.32% | 4.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 82.26% | 82.26% | 56.87% | 56.87% | 5.40% |
| Operating Income | 2.19% | 2.19% | -62.22% | -62.22% | 31.47% |
| Income Before Tax | -201.86% | -201.86% | 164.15% | 164.15% | -21.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -201.86% | -201.86% | 164.15% | 164.15% | -21.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -201.86% | -201.86% | 164.15% | 164.15% | -21.30% |
| EBIT | 2.19% | 2.19% | -62.22% | -62.22% | 31.47% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -163.87% | -163.87% | 67.06% | 67.06% | -20.63% |
| Normalized Basic EPS | -30.18% | -30.18% | 966.67% | 966.67% | -85.71% |
| EPS Diluted | -163.87% | -163.87% | 67.06% | 67.06% | -20.63% |
| Normalized Diluted EPS | -30.18% | -30.18% | 966.67% | 966.67% | -85.71% |
| Average Basic Shares Outstanding | 59.38% | 59.38% | 58.07% | 58.07% | -0.83% |
| Average Diluted Shares Outstanding | 59.38% | 59.38% | 58.07% | 58.07% | -0.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |